Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson’s disease in diabetic patients
Crossref DOI link: https://doi.org/10.1038/s41598-023-49870-z
Published Online: 2023-12-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Yu-Hsuan
Hsu, Chih-Cheng
Liu, Jia-Sin
Chang, Kuo-Cheng
Huang, Jin-An
Text and Data Mining valid from 2023-12-15
Version of Record valid from 2023-12-15
Article History
Received: 16 July 2023
Accepted: 13 December 2023
First Online: 15 December 2023
Competing interests
: The authors declare no competing interests.